SomnoMed Ltd

SOM

Company Profile

  • Business description

    SomnoMed Ltd provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is engaged in commercializing SomnoDent Mandibular Advancement Splint (MAS) and other oral devices for sleep-related disorders in Australia and overseas. The other products in the company's portfolio include SomMorning Repositioner; SomnoBrux splint, a custom-fit, acrylic splint (dental guard) for upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs cleaning tablets that have been developed to clean oral appliances. Geographically, the company generates maximum revenue from Europe, followed by North America and the Asia Pacific region.

  • Contact

    20 Clarke Street
    Level 3
    Crows Nest
    SydneyNSW2065
    AUS

    T: +61 294670400

    https://www.somnomed.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 June 2026

    Employees

    22

Stocks News & Analysis

stocks

Chart of the Week: Soft earnings growth outlook for Australian banks

The latest take from our equity research analysts.
stocks

Coca-Cola earnings: Billion-dollar brands and consumer engagement remain growth priorities

Despite macro and geopolitical challenges, Coca-Cola managed to increase sales in line with its long-term target.
stocks

Unwarranted drop in ASX share

Jittery investors misinterpret an audit for an existential crisis.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,281.8097.301.06%
CAC 408,313.2414.64-0.18%
DAX 4024,856.15131.70-0.53%
Dow JONES (US)50,078.06110.08-0.22%
FTSE 10010,472.11118.271.14%
HKSE27,266.3883.230.31%
NASDAQ23,088.4114.06-0.06%
Nikkei 22557,650.541,286.602.28%
NZX 50 Index13,507.2860.910.45%
S&P 5006,946.144.330.06%
S&P/ASX 2009,014.8098.801.11%
SSE Composite Index4,131.983.610.09%

Market Movers